Wolverine Asset Management LLC Cytokinetics Inc Put Options Transaction History

Wolverine Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2024 Feb 03, 2025	SELL	$46.36 - $58.62 $203,984 - $257,928	-4,400 Reduced 46.81%	5,000 $235,000
Q2 2024 Aug 01, 2024	SELL	$47.86 - $75.05 $818,406 - $1.28 Million	-17,100 Reduced 64.53%	9,400 $509,000
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $3.07 Million - $5.21 Million	-48,200 Reduced 64.52%	26,500 $1.86 Million
Q4 2023 Feb 01, 2024	BUY	$26.88 - $83.49 $502,656 - $1.56 Million	18,700 Added 33.39%	74,700 $6.24 Million
Q2 2023 Aug 07, 2023	BUY	$32.62 - $40.75 $616,518 - $770,175	18,900 Added 50.94%	56,000 $1.83 Million
Q1 2023 May 08, 2023	SELL	$33.36 - $45.71 $1.36 Million - $1.86 Million	-40,700 Reduced 52.31%	37,100 $1.31 Million
Q4 2022 Feb 01, 2023	BUY	$35.77 - $51.11 $1.85 Million - $2.64 Million	51,700 Added 198.08%	77,800 $3.56 Million
Q3 2022 Nov 10, 2022	BUY	$38.54 - $54.52 $1.01 Million - $1.42 Million	26,100 New	26,100 $1.26 Million

416

128M

4.57M

2.42M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.